| __timestamp | Dr. Reddy's Laboratories Limited | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 7459000 |
| Thursday, January 1, 2015 | 17449000000 | 11831000 |
| Friday, January 1, 2016 | 17834000000 | 25705000 |
| Sunday, January 1, 2017 | 19551000000 | 46181000 |
| Monday, January 1, 2018 | 18265000000 | 59497000 |
| Tuesday, January 1, 2019 | 15607000000 | 65003000 |
| Wednesday, January 1, 2020 | 15410000000 | 74506000 |
| Friday, January 1, 2021 | 16541000000 | 126006000 |
| Saturday, January 1, 2022 | 17482000000 | 126215000 |
| Sunday, January 1, 2023 | 19381000000 | 120161000 |
| Monday, January 1, 2024 | 22873000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Dr. Reddy's Laboratories Limited has consistently outpaced Protagonist Therapeutics, Inc. in R&D spending. From 2014 to 2023, Dr. Reddy's increased its R&D expenses by approximately 84%, peaking in 2024 with a notable 2.3 trillion. In contrast, Protagonist Therapeutics, while showing a steady increase, reached its highest R&D expenditure in 2022, with a modest 126 million.
This disparity highlights the scale and ambition of Dr. Reddy's in the global market, as it invests heavily in new drug development and innovation. Meanwhile, Protagonist's focused approach reflects its strategic investments in niche therapeutic areas. The data for 2024 is incomplete for Protagonist, indicating potential shifts in strategy or reporting. This comparison underscores the diverse strategies companies employ to drive pharmaceutical advancements.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending